March 2017 FDA Recall Drug by Akorn Inc
D-0696-2017 - Failed Dissolution Specifications
This Class II drug recall was voluntarily initiated by Akorn Inc on March 13, 2017 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0696-2017
Failed Dissolution Specifications
03-13-2017
05-10-2017
55,968 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Akorn Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
07-09-2019
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Sulfamethoxazole and Trimethoprim Oral Suspension, USP 200 mg / 40 mg per 5 mL , Grape Flavor, Rx Only, 16 fl oz. (473 mL), HI-TECH PHARMACAL CO., INIC, Amityville, NY 11701, NDC 50383-824-16
Batch or Lot Expiration Information
Lot# 348913, Exp.01/18
Lot# 349552, Exp.03/18
Lot# 349681, Exp. 03/18
Lot# 349683, Exp. 03/18
Lot# 349685, Exp. 03/18
Lot# 349687, Exp. 03/18
Lot# 349689, Exp. 03/18
Lot# 350636, Exp.03/18